Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.05. | Gyre Therapeutics, Inc.: Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes | 1 | GlobeNewswire (USA) | ||
13.05. | GYRE THERAPEUTICS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
09.05. | Gyre Therapeutics, Inc.: Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update | 92 | GlobeNewswire (Europe) | Phase 3 clinical trial evaluating F351 for the treatment of CHB-associated liver fibrosis in the PRC remains on track with data anticipated by early 2025 U.S. IND submission to evaluate F351 for... ► Artikel lesen | |
08.05. | GYRE THERAPEUTICS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
27.03. | GYRE THERAPEUTICS, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
26.03. | Gyre Therapeutics, Inc.: Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update | 319 | GlobeNewswire (Europe) | Data readout from Phase 3 clinical trial in the People's Republic of China ("PRC") evaluating F351 for the treatment of CHB-associated liver fibrosis expected by early 2025 U.S. Phase 2a clinical... ► Artikel lesen | |
21.03. | GYRE THERAPEUTICS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
21.03. | Gyre Therapeutics, Inc.: Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum | 2 | GlobeNewswire (USA) | ||
14.02. | GYRE THERAPEUTICS, INC. - 8-K, Current Report | 4 | SEC Filings |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 582 |
RHEINMETALL | 378 |
TUI | 338 |
GAMESTOP | 310 |
EVOTEC | 261 |
DEUTSCHE LUFTHANSA | 259 |
NEL | 252 |
BAYER | 210 |
TESLA | 201 |
BYD | 183 |
BASF | 157 |
VOLKSWAGEN | 143 |
SNOWFLAKE | 142 |
DEUTSCHE TELEKOM | 140 |
PORSCHE SE | 131 |
APPLE | 121 |
MERCEDES-BENZ | 116 |
ALLIANZ | 111 |
THYSSENKRUPP | 106 |
BROADCOM | 99 |
DEUTSCHE BANK | 98 |
PLUG POWER | 98 |
MICROSOFT | 97 |
COMMERZBANK | 95 |
AIXTRON SE | 91 |